Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Insulin icodec weekly vs insulin degludec daily in type 1 diabetes
NCT04848480Phase 3Completed
- Sponsor
- Novo Nordisk
- Start
- Apr 2021
- Primary completion
- Apr 2022
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 12
01
Overview
A Phase 3 trial of insulin icodec in type 1 diabetes mellitus (T1D), sponsored by Novo Nordisk. Started Apr 2021; status: completed.
02
Drugs
insulin icodec
03
Conditions
type 1 diabetes mellitus (T1D)
Beyond the preview
Go deeper on NCT04848480.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04848480.